Drug intelligence / Profile preview

Fuzheng Kangfu Formula

Development stage: Unknown
Lead developer: Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Fuzheng Kangfu Formula is a Traditional Chinese Medicine (TCM) herbal composition developed by the Affiliated Hangzhou First People's Hospital for use as an adjunct to chemotherapy in patients with pancreatic cancer. The formula is designed based on the TCM principle of "Fuzheng" (strengthening the body's vital energy and resistance) and "Kangfu" (recovery). It is typically administered as an oral decoction alongside standard chemotherapy regimens, such as gemcitabine or albumin-bound paclitaxel, to mitigate treatment-related toxicities, enhance immune function, and improve the quality of life and clinical outcomes for patients with advanced or metastatic pancreatic cancer.

Other names: Fuzheng Kangfu DecoctionFuzheng Kangfu Tang

Beyond the preview

Go deeper on Fuzheng Kangfu Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuzheng Kangfu Formula.

Explore the full profile